Manning & Napier Advisors LLC Has $1.77 Million Holdings in Humana Inc. (NYSE:HUM)

Manning & Napier Advisors LLC cut its holdings in Humana Inc. (NYSE:HUM) by 97.2% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,957 shares of the insurance provider’s stock after selling 237,735 shares during the period. Manning & Napier Advisors LLC’s holdings in Humana were worth $1,765,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Atlas Brown Inc. raised its holdings in shares of Humana by 0.6% in the fourth quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider’s stock valued at $1,611,000 after purchasing an additional 38 shares during the last quarter. Moors & Cabot Inc. raised its holdings in shares of Humana by 2.5% in the third quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider’s stock valued at $519,000 after purchasing an additional 40 shares during the last quarter. OLD National Bancorp IN raised its holdings in shares of Humana by 1.8% in the third quarter. OLD National Bancorp IN now owns 2,613 shares of the insurance provider’s stock valued at $828,000 after purchasing an additional 45 shares during the last quarter. Your Advocates Ltd. LLP increased its holdings in Humana by 81.8% during the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock worth $32,000 after buying an additional 45 shares during the last quarter. Finally, Brooklyn Investment Group increased its holdings in Humana by 6.7% during the third quarter. Brooklyn Investment Group now owns 736 shares of the insurance provider’s stock worth $233,000 after buying an additional 46 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. Piper Sandler boosted their target price on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a report on Wednesday, January 15th. Deutsche Bank Aktiengesellschaft lowered their target price on shares of Humana from $349.00 to $250.00 and set a “hold” rating on the stock in a report on Thursday, October 3rd. Oppenheimer lowered their target price on shares of Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a report on Thursday, October 3rd. Jefferies Financial Group downgraded shares of Humana from a “buy” rating to a “hold” rating and lowered their target price for the stock from $519.00 to $253.00 in a report on Monday, October 7th. Finally, Sanford C. Bernstein raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price objective for the company in a research report on Tuesday, October 8th. Nineteen analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, Humana has an average rating of “Hold” and a consensus price target of $297.68.

Insider Buying and Selling at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.32% of the company’s stock.

Humana Stock Performance

Humana stock opened at $296.88 on Friday. The business has a 50 day moving average of $275.44 and a 200-day moving average of $303.07. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. The company has a market capitalization of $35.75 billion, a P/E ratio of 26.30, a P/E/G ratio of 2.15 and a beta of 0.55.

Humana (NYSE:HUM) last released its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. The business had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. On average, equities research analysts predict that Humana Inc. will post 16.11 earnings per share for the current year.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.